ライフサイエンスコーパス: echocardiography

1 to the guidelines of the American Society of Echocardiography.

2 reperfused or nonreperfused infarction using echocardiography.

3 ndergo electrocardiography and transthoracic echocardiography.

4 ular function were assessed by histology and echocardiography.

5 underwent 3-dimensional (3D) transesophageal echocardiography.

6 ysical examination, electrocardiography, and echocardiography.

7 WT mice, showed no signs of heart failure by echocardiography.

8 dium, and diastolic function was assessed by echocardiography.

9 n the side of ocular arterial occlusion, and echocardiography.

10 sponse to dobutamine was assessed in vivo by echocardiography.

11 but its measurement requires transesophageal echocardiography.

12 history were evaluated by (speckle-tracking) echocardiography.

13 on indices were analyzed using 3-dimensional echocardiography.

14 re, they were reassessed using transthoracic echocardiography.

15 c fetal heart muscle using contrast-enhanced echocardiography.

16 ears; range, 69-85; 4 men), not suspected on echocardiography.

17 ypically require intraprocedural guidance by echocardiography.

18 moderate exercise with pre- and postexercise echocardiography.

19 s with detectable tricuspid regurgitation on echocardiography.

20 culated using 2-dimensional speckle-tracking echocardiography.

21 d heart failure, and underwent comprehensive echocardiography.

22 cquisition quality for focused critical care echocardiography.

23 invasive hemodynamic monitoring and Doppler echocardiography.

24 essment of multiple VWF laboratory tests and echocardiography.

25 s shown by both pressure-volume analysis and echocardiography.

26 ymptom questionnaires, and dobutamine stress echocardiography.

27 approach from the RA guided by intracardiac echocardiography.

28 assessed using transthoracic saline contrast echocardiography.

29 rial who were in sinus rhythm at the time of echocardiography.

30 to 1.7% (p = 0.001) on early post-operative echocardiography.

31 clinical examination, laboratory tests, and echocardiography.

32 re (PASP) was serially assessed with Doppler echocardiography.

33 in Communities) who underwent transthoracic echocardiography.

34 l location, LV scar is often not detected by echocardiography.

35 oppler imaging and 2-dimensional (2D) strain echocardiography.

36 ing was assessed with same-day transthoracic echocardiography.

37 standardized inspiration using transthoracic echocardiography.

38 nally measured and quantitated using Doppler echocardiography.

39 m diagnostic testing including comprehensive echocardiography.

40 and LAHB and no obvious cardiac pathology by echocardiography.

41 compared with measurements from intracardiac echocardiography.

42 ons were detected by electrocardiography and echocardiography.

43 ght be more compatible with the precision of echocardiography.

44 ddition to transthoracic and transesophageal echocardiography 1 to 3 months post-TAVR.

45 of 2010 ESC recommendations; 11.2% required echocardiography, 1.7% exercise stress test, 1.2% Holter

46 LV function was assessed by serial echocardiography, 2,3,5-triphenyltetrazolium chloride st

47 ve opening (%untwMVO) using speckle-tracking echocardiography, (2) coronary flow reserve, (3) pulse w

48 the ability of two-dimensional transthoracic echocardiography (2D-TTE) to determine causes of acute c

49 cardiac CT and 3-dimensional transesophageal echocardiography (3D-TEE) were retrospectively evaluated

50 iovascular procedures were common, including echocardiography (59%), electrophysiology study or ablat

51 Follow-up echocardiography after 15 +/- 4 months demonstrated cont

52 After coronary angiography and echocardiography, all underwent CMR and, when indicated,

53 Three-dimensional echocardiography allows noninvasive and patient-specific

54 p into preadolescence (8-12 years of age) by echocardiography and 3-dimensional shape computational a

55 Baseline echocardiography and a composite endpoint (cardiovascula

56 cardiac valve disease, and performing early echocardiography and antiphospholipid dosages in patient

57 etected by transthoracic and transesophageal echocardiography and by cardiac magnetic resonance.

58 btained by routine clinical practice between echocardiography and cardiac magnetic resonance (CMR) an

59 nvolves an integrated approach to the use of echocardiography and cardiac magnetic resonance imaging

60 Echocardiography and cardiac magnetic resonance imaging

61 In contemporary cardiology practice, echocardiography and cardiac magnetic resonance imaging

62 median age, 52.8+/-15.1 years) who underwent echocardiography and CMR imaging within 6 months (median

63 n plot, mean maximal LVWT difference between echocardiography and CMR was 0.5 mm (95% confidence inte

64 n 17.1% and 12.8% of patients as measured by echocardiography and CMR, respectively.

65 Using transthoracic echocardiography and coronary computed tomography angiog

66 care trainees learning focused critical care echocardiography and examined the tool for evidence of v

67 dilated aortic root (>/=4 cm) that underwent echocardiography and gated contrast-enhanced thoracic ao

68 Indexes from transthoracic echocardiography and hemodynamic evaluation also proved

69 Cardiac structure assessed by echocardiography and histology was normal in both transg

70 ation and oxidative damage) were assessed by echocardiography and histopathological examination along

71 additional cardiac functional studies using echocardiography and identified further cardiac function

72 sternal long and short axis by 2-dimensional echocardiography and in short axis by CMR.

73 ed with hemodynamic changes characterized by echocardiography and left ventricle/right ventricle cath

74 Transthoracic echocardiography and lung ultrasound are noninferior to

75 othesize that a combination of transthoracic echocardiography and lung ultrasound is noninferior to c

76 ricular fibrosis, as evaluated in vivo using echocardiography and magnetic resonance.

77 d and twenty-five patients underwent Doppler echocardiography and multidetector computed tomography w

78 d and twenty-five patients underwent Doppler echocardiography and multidetector computed tomography w

79 Patients underwent phenotyping by echocardiography and plasma N-terminal pro-brain natriur

80 Diastolic function was investigated with echocardiography and pressure-volume analysis; passive s

81 MyBPC(PKA-) and DBL(PKA-) mice, and in vivo echocardiography and pressure-volume catheterization stu

82 mography (CT), pulmonary artery pressures at echocardiography and right-sided heart catheterization,

83 ose of critical care physicians certified in echocardiography and scored according to the focused cri

84 Using two-dimensional echocardiography and speckle tracking analysis, this stu

85 ucture and function were evaluated by serial echocardiography and terminal invasive hemodynamics.

86 missed because of the limited specificity of echocardiography and the traditional requirement for his

87 modalities, including both speckle tracking echocardiography and tissue tracking by cardiac magnetic

88 onance imaging, cardiac catheterization, and echocardiography) and indexed to body surface area (card

89 ting and measurement of left ventricular EF (echocardiography) and then cardiac catheterization, wher

90 all (P<0.05) reduction in ejection fraction (echocardiography), and increases in the cardiac levels o

91 nesis, dilation, and hypertrophy observed on echocardiography, and 40% reduction in right ventricular

92 nt clinical assessment, electrocardiography, echocardiography, and biomarker measurement (NT-proBNP,

93 ardiomyocyte cell death, electrocardiograms, echocardiography, and cardiac angiography.

94 analysis, cardiopulmonary exercise testing, echocardiography, and cardiac magnetic resonance includi

95 =71) underwent detailed clinical assessment, echocardiography, and invasive hemodynamic exercise test

96 at a single center with electrocardiography, echocardiography, and laboratory testing.

97 was assessed by conventional and deformation echocardiography, and myocarditis severity graded on his

98 critically ill), patients undergoing stress echocardiography, and patients with pulmonary hypertensi

99 n by pulmonary function tests, transthoracic echocardiography, and polysomnography 3 months after ICU

100 At week 6, PH status was confirmed by echocardiography, and rats were randomly assigned to veh

101 function, global hemodynamics assessed with echocardiography, and serological markers of endothelial

102 s, clinical data, invasive hemodynamic data, echocardiography, and vital status for all patients refe

103 phics, clinical data, invasive hemodynamics, echocardiography, and vital status for all patients.

104 s for RVLS by 2-dimensional speckle-tracking echocardiography; and (2) their relationship with demogr

105 n but remains a diagnostic challenge because echocardiography as a first-line test may be limited.

106 its of the 2005 and 2015 American Society of Echocardiography (ASE) and 95th percentile of reference

107 The focused critical care echocardiography assessment tool demonstrated evidence o

108 cored according to the focused critical care echocardiography assessment tool.

109 Transoesophageal echocardiography at 1 month showed that all shunts were

110 In banded cats, echocardiography at 4-months revealed concentric left ve

111 12) for 1 week prior to myocardial contrast echocardiography at 85% of gestation.

112 surface area was quantified by 3-dimensional echocardiography at baseline and after 58 +/- 5 days, fo

113 Echocardiography at day 3 post-myocardial infarction sug

114 lar ejection fraction (LVEF) was assessed by echocardiography at entry, 6 and 12 months postpartum.

115 alvular heart disease subjects who underwent echocardiography at our institution and an external accr

116 with >/=3+ primary MR and LVEF >/=60% using echocardiography at rest; they were evaluated at our cen

117 Exercise testing, echocardiography, B-type natriuretic peptide, functional

118 is pilot study, we evaluated whether a novel echocardiography-based assessment of myocardial microstr

119 ring cancer treatment, she was observed with echocardiography (baseline left ventricular ejection fra

120 72 hr), animals (>/= 6 per group) underwent echocardiography, blood and urine sampling, and had kidn

121 Echocardiography, blood pressure and HRV were examined.

122 ure (femoral venous access with intracardiac echocardiography but no IASD placement).

123 ventricular dysfunction using goal-directed echocardiography can and should be performed by pulmonar

124 s compact and battery operated, and handheld echocardiography can be readily performed at the point o

125 y used noninvasive imaging techniques in CHD-echocardiography, cardiac magnetic resonance imaging, an

126 ariables from standardized exercise testing, echocardiography, cardiac magnetic resonance imaging, se

127 Patients were evaluated by echocardiography, cardiovascular magnetic resonance, and

128 ability index with a prespecified acceptable echocardiography-catheterization difference of <10 mm Hg

129 Left ventricular function (echocardiography), clinical status (New York Heart Assoc

130 At latest follow-up, echocardiography confirmed mild or no residual MR in all

131 The speckle tracking echocardiography data were normalized in reference to 47

132 Standard echocardiography data were obtained.

133 Baseline clinical and echocardiography data were recorded, and the Society of

134 sought to determine QAV frequency in a large echocardiography database, to characterize associated ca

135 Echocardiography demonstrated increased interventricular

136 Her echocardiography demonstrated normal sinus rhythm at 73

137 spective cohort study was carried out at the echocardiography department of Sudan Heart Center in Kha

138 e was agreement between catheterization- and echocardiography-derived mean gradients calculated by us

139 ementation of 2-dimensional speckle-tracking echocardiography-derived RV analysis in clinical practic

140 06, and December 31, 2012, with clinical and echocardiography diagnoses of hemodynamically significan

141 The echocardiography-driven cardiac output optimization prot

142 sure (BP) responses during dobutamine stress echocardiography (DSE) are associated with abnormal test

143 tion velocity were assessed by transthoracic echocardiography during a prolonged intracoronary saline

144 Subcostal transthoracic echocardiography during catheter insertion.

145 onse to mechanical unloading was assessed by echocardiography during turndown of the LVAD.

146 type natriuretic peptide) and rest/exercise echocardiography (E/e' ratio) to make this determination

147 Increased use of echocardiography (echo) raises questions of whether echo

148 I quantification and the recommended Doppler echocardiography (ECHO)-derived integrative approach to

149 ination, fasting metabolic and lipid panels, echocardiography, electrocardiography, and 6-minute walk

150 rmalities could be noninvasively captured by echocardiography, electrocardiography, and magnetic reso

151 Patients had clinical and echocardiography evaluations at baseline and months 1 an

152 t disease was defined as history or baseline echocardiography evidence of at least moderate aortic/mi

153 nos (ECHO-SOL) and underwent a comprehensive echocardiography examination to define left ventricular

154 scores with increasing focused critical care echocardiography experience were compared by using t tes

155 aluated blood pressure, cardiac function (by echocardiography), fibrosis (with Masson Trichrome stain

156 ac performance was assessed by transthoracic echocardiography following experimental baroreflex dysfu

157 tion and cardiac function was assessed using echocardiography for 8 weeks followed by a terminal meas

158 All patients underwent speckle-tracking echocardiography for measurement of left ventricular lon

159 ) use of (3-dimensional) myocardial contrast echocardiography for selecting the correct septal (sub)b

160 Patients referred for echocardiography from June 1, 1991, through November 31,

161 Echocardiography, given its safety, easy availability, a

162 Transesophageal echocardiography guidance decreased from 60.7% to 32.3%

163 Transesophageal echocardiography-guided beating-heart MV repair with exp

164 Echocardiography-guided heart rate optimization results

165 ncreased significantly in 79% patients using echocardiography-guided pacemaker optimization (2.21 L/m

166 Echocardiography-guided pacemaker optimization is used i

167 Echocardiography-guided pacemaker optimization of cardia

168 Current Doppler echocardiography guidelines recommend using early to lat

169 Screening echocardiography has emerged as a potentially powerful t

170 triage; however, comprehensive transthoracic echocardiography has limited availability.

171 echniques (and specifically speckle-tracking echocardiography) have been shown to have clinical utili

172 c resonance imaging, and myocardial contrast echocardiography, have emerged as techniques with great

173 TKE may provide complementary information to echocardiography, helping to distinguish within the hete

174 ystolic pressure, estimated noninvasively by echocardiography, helps identify SCD patients at risk fo

175 The utility of screening echocardiography hinges on the rate of RHD progression a

176 rainees' efficiency in focused critical care echocardiography image acquisition improved quickly in t

177 Echocardiography, immunostaining, flow cytometry, quanti

178 A thrombus was identified on transesophageal echocardiography in 10 (21%) patients (OAC=9; no OAC=1).

179 s validated by measuring the 4 parameters by echocardiography in 100 subjects with EF ranging from 16

180 sed LA function measured by speckle-tracking echocardiography in 357 patients with HFpEF enrolled in

181 This review appraised speckle-tracking echocardiography in a clinical context by providing a cr

182 Physicians can be taught bedside echocardiography in a time-effective manner with positiv

183 e existing literature on the use of handheld echocardiography in conducting focused cardiac examinati

184 n as measured by 2-dimensional transthoracic echocardiography in contrast to 67.1% in controls at 21-

185 lows' and intensivists' use of goal-directed echocardiography in diagnosing right ventricular dysfunc

186 Although maximal LVWT by echocardiography in general measured similar to CMR, dis

187 Our objective was to define the use of echocardiography in pregnancies complicated by gestation

188 ompared to transthoracic and transesophageal echocardiography in the diagnostic evaluation of cryptog

189 c structure and function were evaluated with echocardiography in vivo.

190 s for the use of bedside cardiac ultrasound, echocardiography, in the ICU.

191 Although echocardiography including 2-dimensional and 3-dimension

192 underwent cardiopulmonary exercise testing, echocardiography including tissue-Doppler imaging and sp

193 Use of stress echocardiography increased by 27.8% from 2005 (709 tests

194 Echocardiography is a valuable tool to stratify risk and

195 Echocardiography is also used during surveillance, but i

196 Echocardiography is commonly used to direct the manageme

197 Exercise echocardiography is often applied as a noninvasive strat

198 As a consequence, the use of handheld echocardiography is on the rise even among nonechocardio

199 Echocardiography is the gold standard for evaluation of

200 Echocardiography is the primary imaging modality for dia

201 Echocardiography is the quintessential imaging technique

202 ng embraced and increasingly adopted in many echocardiography laboratories worldwide.

203 TTEs from 2001 to 2016 completed at a large echocardiography laboratory.

204 Cardiac magnetic resonance imaging, echocardiography, left ventricular and LA pressure-volum

205 stroke volume index undergoing AVR underwent echocardiography, magnetic resonance imaging, a 6-minute

206 Echocardiography, magnetic resonance imaging, and pressu

207 nt clinical evaluation, electrocardiography, echocardiography, magnetic resonance imaging, and whole

208 ith similar findings on laboratory tests and echocardiography may be treated based on algorithms for

209 omises specificity, suggesting that exercise echocardiography may help rule out HFpEF.

210 dy underwent a health examination, including echocardiography measurement of GLS.

211 effect of doxycycline on CAVD progression by echocardiography, MMP-targeted micro single photon emiss

212 two-dimensional (2D) speckle tracking (2DST) echocardiography myocardial strain measurement remain sc

213 ed to assess permeability (n = 4 per group), echocardiography (n = 4 per group), and right and left v

214 ith the aortic valve location ratio and with echocardiography (n = 53).

215 Doppler echocardiography of AC9(-/-) displays a decrease in the

216 Echocardiography of Mybphl heterozygous and null mouse h

217 iameter (SVC) measured using transesophageal echocardiography, of inferior vena cava diameter (IVC) m

218 diameter (IVC) measured using transthoracic echocardiography, of the maximal Doppler velocity in lef

219 In echocardiography, only the maximal LA volume is included

220 from the introduction of CPET combined with echocardiography or CPET imaging, which provides basic i

221 ectrocardiography, nuclear stress, or stress echocardiography) or anatomic testing.

222 ectrocardiography, nuclear stress, or stress echocardiography) or coronary computed tomography angiog

223 ital heart diseases (CHD) referred for CCTA, echocardiography, or magnetic resonance imaging.

224 ost-TAVR clinical events compared with early echocardiography (p < 0.01).

225 ollow-up assessed both through transthoracic echocardiography (P=0.0167 versus baseline) and cardiac

226 rt (CRIC) Study participants who had Doppler echocardiography performed were considered for inclusion

227 n admission, and 2-dimensional transthoracic echocardiography performed within 48 hours.

228 Echocardiography (performed in 144 and 146 patients rand

229 therapeutic decision-making and monitoring, echocardiography plays a pivotal role in the care of HF

230 longitudinal deformation by speckle-tracking echocardiography predict ventricular tachyarrhythmias an

231 Echocardiography provides important long-term prognostic

232 ed by NFUS correlated well with intracardiac echocardiography (r=0.86; P<0.0001).

233 pes, severe right ventricular dysfunction on echocardiography, ratio of right atrial/pulmonary capill

234 ermining AR severity post-TAVR using Doppler echocardiography remains challenging.

235 o $514 for pharmacologic and exercise stress echocardiography, respectively; and $946 to $1132 for ex

236 Transthoracic echocardiography revealed a mean+/-SD ejection fraction

237 Echocardiography revealed an embolic source in 61% of CR

238 METHODS AND Echocardiography revealed atrial enlargement, atrial tis

239 Echocardiography revealed transiently increased systolic

240 llation on electrocardiogram with subsequent echocardiography revealing myxomatous mitral valve with

241 Echocardiography showed a filling defect at the apex of

242 Echocardiography showed a small, stable reduction in lef

243 T was significantly increased in blood, and echocardiography showed increased heart wall thickness a

244 Echocardiography showed left ventricular hypokinesis.

245 At 30 days, transthoracic echocardiography showed mild (1+) central MR in 1 patien

246 odeficient mice showed good engraftment, and echocardiography showed significant functional improveme

247 Echocardiography showed that doxorubicin treatment cause

248 , assessed by transthoracic saline contrast echocardiography, significantly increased as PaO2 decrea

249 oderate- or greater-severity aortic stenosis echocardiography studies with concomitant catheterizatio

250 ed physicians after 20 focused critical care echocardiography studies.

251 o CMR, discordance because of limitations in echocardiography technique was present in a significant

252 ous echo contrast (LASEC) by transesophageal echocardiography (TEE) has been proposed as an important

253 ndergoing investigation with transesophageal echocardiography (TEE).

254 ectrocardiography (EKG), and transesophageal echocardiography (TEE).

255 by cardioversion approach (transoesophageal echocardiography [TEE] or not), anticoagulant experience

256 old is more compatible with the precision of echocardiography than that obtained by end-expiratory oc

257 gressive aortic root dilation as assessed by echocardiography that can be attenuated by treatment wit

258 protocol, we assessed cardiac function using echocardiography, the myofilament-Ca(2)(+) response of d

259 All BAVnon-dil patients underwent follow-up echocardiography to assess aortic growth rate.

260 est that MostCare could be an alternative to echocardiography to assess cardiac output in ICU patient

261 derwent cardiopulmonary exercise testing and echocardiography to assess systolic and diastolic functi

262 rs systematically employed exercise (stress) echocardiography to define those patients without obstru

263 des symptoms, needing active surveillance by echocardiography to determine the optimum time for aorti

264 into the heart and guided by transesophageal echocardiography to the ventricular surface of the prola

265 x trainees completed a focused critical care echocardiography training curriculum followed by perform

266 magnetic resonance (CMR) over transthoracic echocardiography (TTE) in ischemic cardiomyopathy and no

267 The diagnostic value of transthoracic echocardiography (TTE) in the detection of PFO in patien

268 ves have been shown to improve transthoracic echocardiography (TTE) ordering practices of physicians

269 In 90 patients (92.8%), echocardiography underestimated (n=32; 33.0%) or overest

270 n, as identified by means of transesophageal echocardiography, underwent additional balloon dilation

271 ompared with myocardial function measured by echocardiography using Pearson's correlation.

272 rops are routinely assessed noninvasively by echocardiography using the Bernoulli principle.

273 Using only speckle tracking echocardiography variables, associative memory classifie

274 Transesophageal echocardiography velocities modestly but significantly (

275 site of activation under direct intracardiac echocardiography visualization.

276 al-directed echocardiogram and transthoracic echocardiography was 21 hours 18 minutes.

277 an left ventricular mass index measured with echocardiography was normal in all the 3 subgroups.

278 and history were obtained, and transthoracic echocardiography was performed according to a standardiz

279 Transesophageal echocardiography was performed during follow-up in 47/50

280 MV imaging using 3D transesophageal echocardiography was performed in 10 normal subjects and

281 Two-dimensional transthoracic echocardiography was performed in 1818 participants of t

282 METHODS AND Two-dimensional echocardiography was performed in 427 patients with hype

283 Echocardiography was performed on 3,474 individuals (mea

284 Gold standard transthoracic echocardiography was performed on schedule unless the go

285 Stress echocardiography was performed to estimate myocardial wo

286 At the end of the study, echocardiography was repeated, with additional RV pressu

287 rotic tissue increased and myocardial strain echocardiography was significantly compromised in CMBK-d

288 An iterative method with Doppler echocardiography was used to assess changes in cardiac o

289 0.163), and two-dimensional speckle-tracking echocardiography was used to assess LV structure and fun

290 Echocardiography was used to estimate the left ventricul

291 Standard transthoracic echocardiography was used to obtain apical four-chamber

292 According to echocardiography, we found that Efnb3 gene knockout mice

293 systolic pressure (PASP) assessed by Doppler echocardiography were made during the exposure.

294 ECG and echocardiography were used to evaluate possible cardiac

295 T/CT and other imaging techniques, including echocardiography, were collected.

296 It preserved heart function, assessed by echocardiography, while protecting against adverse cardi

297 of the thorax and abdomen and tissue Doppler echocardiography with myocardial strain measured by spec

298 of the present study was to compare Doppler echocardiography with the pulse contour method MostCare

299 tector computed tomography, and intracardiac echocardiography, with arrhythmia foci being mapped at e

300 h complete cardiology-reviewed transthoracic echocardiography within 48 hours for comparison.